Otorhinolaringology Section, Department of Biomedicine, Neuroscience and Advanced Diagnostics, Azienda Ospedaliera Universitaria Policlinico ''Paolo Giaccone'', University of Palermo, Via del Vespro, 133, Palermo, 90127, Italy.
Young-Otolaryngologists of the International Federation of Oto-Rhino-Laryngological Societies (YO-IFOS) Study Group, Paris, France.
Eur Arch Otorhinolaryngol. 2024 Dec;281(12):6229-6238. doi: 10.1007/s00405-024-08852-1. Epub 2024 Jul 28.
The control of epistaxis has always posed a significant challenge for otolaryngologists. One of the most viable options to address refractory cases is the ligation or cauterization of the sphenopalatine artery. The objective of this study was to assess the efficacy, safety, and long-term outcomes of these interventions.
Two independent otolaryngologists conducted a comprehensive search for studies dealing with management of uncontrolled/recurrent epistaxis by consulting the main scientific databases on the web, including PubMed, Google Scholar, Medline, EMBASE, Web of Science, and the Cochrane Library. The systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. The criteria for considering studies for the review were based on the population, intervention, comparison, outcome, timing and setting (PICOTS) framework.
Sixteen studies were included in the systematic review, comprising a total of 454 patients. Among these, 289 individuals underwent ligation of the sphenopalatine artery, while 100 underwent cauterization of the same artery. Additionally, 56 patients underwent both ligation and cauterization of the sphenopalatine artery during the same surgery. The incidence of rebleeding and complications was respectively 12.1% (55/454) and 3% (14/454), resulting in relatively low rates in both cases.
Our review emphasizes the increasing importance of surgical approaches, specifically ligation or cauterization of the sphenopalatine artery, in addressing refractory cases. The low incidence of complications, predominantly temporary decreased lacrimation in patients undergoing ligation of the sphenopalatine artery, highlights the safety and feasibility of these interventions.
控制鼻出血一直是耳鼻喉科医生面临的重大挑战。解决难治性病例的最可行方法之一是结扎或电凝蝶腭动脉。本研究旨在评估这些干预措施的疗效、安全性和长期效果。
两名独立的耳鼻喉科医生通过咨询主要的网络科学数据库,包括 PubMed、Google Scholar、Medline、EMBASE、Web of Science 和 Cochrane Library,对涉及通过管理失控/复发性鼻出血的研究进行了全面搜索。系统评价根据系统评价和荟萃分析的首选报告项目(PRISMA)声明进行。考虑纳入评价的研究标准基于人群、干预、比较、结果、时间和地点(PICOTS)框架。
系统评价共纳入 16 项研究,共纳入 454 例患者。其中,289 例患者接受了蝶腭动脉结扎术,100 例患者接受了蝶腭动脉电凝术,56 例患者在同一次手术中同时接受了蝶腭动脉结扎和电凝术。再出血和并发症的发生率分别为 12.1%(55/454)和 3%(14/454),两种情况下的发生率均相对较低。
我们的综述强调了手术方法的重要性日益增加,特别是结扎或电凝蝶腭动脉,以解决难治性病例。并发症发生率低,主要是接受蝶腭动脉结扎术的患者暂时泪液减少,突出了这些干预措施的安全性和可行性。